Rejuvenating Fertility Center (RFC) Offers PRP Ovarian Therapy As Alternative to Donor Eggs

NEW YORK, NY / ACCESSWIRE / September 19, 2022 / Groundbreaking new technology offers women nearing, experiencing, or even past menopause hope of achieving pregnancy with their own eggs. Rejuvenating Fertility Center (RFC), based in New York and Connecticut, offers not only local but worldwide fertility treatments to patients. The clinic is pleased to announce that, after pioneering a new service in the northeast, it now offers platelet-rich plasma (PRP) ovarian rejuvenation as a fertility treatment option.

PRP therapy has been seen in the news and social media frequently; as it pertains to skin care and facial rejuvenation, it has earned itself the nickname "the vampire facial". Favored by a growing number of celebrities and social personalities, PRP therapy as facial rejuvenation has been featured in major media outlets such as Allure and Cosmopolitan but it is now known to work in reproductive health.

This new technology has multiple benefits. PRP therapy is a cutting-edge treatment which utilizes the body's own plasma to accelerate healing at the injection site. As it pertains to fertility, PRP ovarian rejuvenation features a PRP injection given vaginally into the ovaries, guided by ultrasound. PRP therapy is best used alongside more non-traditional in vitro fertilization (IVF) treatments. This new therapy is capable of improving egg quantity and quality. Recent studies have shown that PRP can increase blood AMH levels indicating improvement in ovarian reserve. It also, when given inside the uterus, can improve implantation and lower the chances of a miscarriage.

RFC staff has disclosed that the typical patient for this new treatment is one who has experienced multiple failed IVF treatments. This technology is a vital breakthrough for women who have suffered failed embryo formation, have poor egg or embryo quality, have recurrent implantation failure, as it offers new hope for these women to become pregnant and experience live birth.

PRP therapy has helped women with diminished ovarian reserve, premature ovarian insufficiency (POI), and even early menopause achieve pregnancy using their own eggs. This is vital to the fertility industry, as it is seeing record numbers of older women attempting to become pregnant who are told that they need donor eggs. The number of pregnancies in women over 35 is rising: according to the National Women's Health Network, 1 in 6 pregnant women in the US in 2019 were over 35.

Thus, there is an increasing need for more effective and diverse fertility treatments. Women are marrying later or not marrying at all, choosing to focus on establishing a career prior to considering childbirth. As most women face declining fertility after 35, novel treatments such as PRP therapy are in high demand. The fertility specialists at RFC are headed by Dr. Zaher Merhi, MD, a board-certified reproductive endocrinologist. He is also the founder and medical director of Rejuvenating Fertility Center, Manhattan and Connecticut's first IVF Center to utilize non-conventional fertility methods.